These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8198934)

  • 1. Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. The Venous Thromboembolism Study Group of the Spanish Society of Clinical Pharmacology.
    Vallès JA; Vallano A; Torres F; Arnau JM; Laporte JR
    Br J Clin Pharmacol; 1994 Mar; 37(3):255-9. PubMed ID: 8198934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of venous thromboembolism risk and prophylaxis among hospitalized patients in Brazzaville].
    Ikama SM; Nkoua MF; Gombet TR; Makani J; Mongo-Ngamami S; Ondze-Kafata LI; Ellenga-Mbolla BF; Kimbally-Kaky G
    J Mal Vasc; 2016 May; 41(3):182-7. PubMed ID: 26970811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of venous thromboembolism in Irish hospitals.
    McCarthy JE; O'Donnell JR
    Ir Med J; 1993; 86(6):199-202. PubMed ID: 8106228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
    Bratzler DW; Raskob GE; Murray CK; Bumpus LJ; Piatt DS
    Arch Intern Med; 1998 Sep; 158(17):1909-12. PubMed ID: 9759687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The PROMET study: Prophylaxis for venous thromboembolic disease in at-risk patients hospitalized in Algeria].
    Guermaz R; Belhamidi S; Amarni A
    J Mal Vasc; 2015 Jul; 40(4):240-7. PubMed ID: 26051861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
    Schousboe JT; Brown GA
    J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.
    Bâ SA; Badiane SB; Diop SN; Diouf FS; Fall D; Ka MM; Kane A; Ndiaye M;
    Arch Cardiovasc Dis; 2011 Oct; 104(10):493-501. PubMed ID: 22044701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of enoxaparin for the prophylaxis of venous thromboembolism in major orthopedic surgery patients].
    Brosa Riestra M; Rubio-Terrés C; Nadipelli V; Casado Collado A; Martínez Brotons F
    Farm Hosp; 2003; 27(4):210-8. PubMed ID: 12966450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of venous thromboembolism prophylaxis for surgical patients: a multicentre analysis of practice in Spain.
    Otero R; Uresandi F; Cayuela A; Blanquer J; Cabezudo MA; De Gregorio MA; Lobo JL; Nauffal D; Oribe M
    Eur J Surg; 2001 Mar; 167(3):163-7. PubMed ID: 11316398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of venous thromboembolic disease in the critical patient: an assessment of clinical practice in the Community of Madrid].
    García-Olivares P; Guerrero JE; Tomey MJ; Hernangómez AM; Stanescu DO
    Med Intensiva; 2014; 38(6):347-55. PubMed ID: 24055041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventing venous thromboembolism].
    Encke A; Haas S
    Chirurg; 2007 Feb; 78(2):110, 112-8. PubMed ID: 17265054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
    Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of ENDORSE study in Hungary. Multinational, cross-sectional study to assess the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
    Losonczy H; Tar A;
    Orv Hetil; 2008 Nov; 149(44):2069-76. PubMed ID: 18952526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
    Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
    J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.